Stocktoria

Alpha Tau Medical Ltd. DRTS

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-08

Alpha Tau Medical Ltd. statistics & valuation

Market cap$957.5M
P / B12.4×
Return on equity-55.3%
Return on capital-44.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-32.00% -34.50% -50.70% -55.30% 202020212022202320242025
Shares outstanding
40.4M 40.5M 69.1M 69.7M 70.4M 88.0M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-16.80% -64.60% -28.10% -27.20% -36.80% -40.30% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.22 -$0.67 -$0.53 -$0.42 -$0.45 -$0.53 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-40.3%-36.8%-27.2%-28.1%-64.6%-16.8%
Return on equity-55.3%-50.7%-34.5%-32.0%78.4%105.4%
Current ratio7.457.4012.0724.557.4122.73

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.